Comparative Study between DNA Copy Number Aberrations Determined by Quantitative Microsatellite Analysis and Clinical Outcome in Patients with Stomach Cancer

Clinical Cancer Research

Volumn 10, Issue 9, 2004, Pages 3013-3019

  Suzuki, Seiji ^a   Egami, Kaku ^a   Sasajima, Koji ^a   Ghazizadeh, Mohammad ^a   Shimizu, Hajime ^a   Watanabe, Hidehiro ^a   Hasegawa, Hirokazu ^a   Iida, Shinya ^a   Matsuda, Takeshi ^a   Okihama, Yuji ^a   Hosone, Masaru ^a   Shimizu, Kazuo ^a   Kawanami, Oichi ^a   Tajiri, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 CARBOXYFLUORESCEIN; 6 CARBOXYTETRAMETHYLRHODAMINE; DNA; RHODAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME 16Q; CHROMOSOME 20Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC MARKER; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RELATIVE DNA COPY NUMBER; STOMACH CANCER; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 20; CHROMOSOMES, HUMAN, PAIR 8; DNA, NEOPLASM; FEMALE; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMERASE CHAIN REACTION; PROPORTIONAL HAZARDS MODELS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 2442564508     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-03-0250     Document Type: Article

References (41)

1. Aiko T, Sasako M. The new Japanese classification of gastric carcinoma: points to be revised. Gastric Cancer 1998;1:25-30.
2. Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis. Cancer 1995;75:1410-7.
3. Igarashi J, Nimura Y, Fujimori M, et al. Allelic loss of the region of chromosome 1p35-pter is associated with progression of human gastric carcinoma. Jpn J Cancer Res 2000;91:797-801.
4. Sano T, Tsujino T, Yoshida K, et al. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res 1991;51:2926-31.
5. Uchino S, Tsuda H, Noguchi M, et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res 1992;52:3099-102.
6. Yustein AS, Harper JC, Petroni GR, Cummings OW, Moskaluk CA, Powell SM. Allelotype of gastric adenocarcinoma. Cancer Res 1999; 59:1437-41.
7. Suzuki S, Tenjin T, Watanabe H, Matsushima S, Shibuya T, Tanaka S. Low level c-myc gene amplification in gastric cancer detected by dual color fluorescence in situ hybridization analysis. J Surg Oncol 1997;66: 173-8.
8. Nessling M, Solinas-Toldo S, Wilgenbus KK, et al. Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCN, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 1998;23:307-16.
9. Hattori Y, Odagiri H, Nakatani H, Miyagawa K, et al. K-sam, an amplified gene in stomach cancer, is a member of the heparin-binding growth factor receptor genes. Proc Natl Acad Sci USA 1990;87:5983-7.
10. Sakakura C, Hagiwara A, Yasuoka R, et al. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int J Cancer 2000;89:217-23.
11. Sakakura C, Hagiwara A, Yasuoka R, et al. Tumor-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br J Cancer 2001;84:824-31.
12. Takahama Y, Yamada Y, Emoto Y, et al. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer 2002;5:61-8.
13. Kubicka S, Claas C, Staab S, et al. p53 mutation pattern and expression of c-erbB2 and c-met in gastric cancer: relation to histological subtypes, Helicobacter pylori infection, and prognosis. Dig Dis Sci 2002;47:114-21.
14. Hiyama T, Haruma K, Kitadai Y, et al. K-ras mutation in helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer. Int J Cancer 2002;97:562-6.
15. Cho JH, Noguchi M, Ochiai A, Hirohashi S. Loss of heterozygosity of multiple tumor suppressor genes in human gastric cancers by polymerase chain reaction. Lab Invest 1996;74:835-41.
16. Uchino S, Tsuda H, Noguchi M, et al. Frequent loss of heterozygosity at DCC locus in gastric cancer. Cancer Res 1992;52:3099-102.
17. Huiping C, Kristjansdottir S, Bergthorsson JT, et al. High frequency of LOH, MSI and abnormal expression of FHIT in gastric cancer. Eur J Cancer 2002;38:728-35.
18. Ascano JJ, Frierson H, Moskaluk CA, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol 2001;14:942-9.
19. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002;109:113-24.
20. Nakayama H, Yasui W, Yokozaki H, Tahara E. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 1993;84:184-90.
21. Sakakura C, Mori T, Sakabe T, et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999; 24:299-305.
22. Nakanishi M, Sakakura C, Fujita Y, et al. Genomic alterations in primary gastric cancers analyzed by comparative genomic hybridization and clinicopathological factors. Hepatogastroenterology 2000;47:658-62.
23. Koo SH, Kwon KC, Shin SY, et al. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet 2000;117:97-103.
24. Guan XY, Fu SB, Xia JC, et al. Recurrent chromosome changes in 62 primary gastric carcinomas detected by comparative genomic hybridization. Cancer Genet Cytogenet 2000;123:27-34.
25. Wu MS, Chang MC, Huang SP, et al. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer 2001;30:80-6.
26. Ginzinger DG, Godfrey TE, Nigro J, et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000;60:5405-9.
27. Suzuki S, Moore DH II, Ginzinger DG, et al. An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res 2000;60:5382-5.
28. Nigro JM, Takahashi MA, Ginzinger DG, et al. Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 2001;158:1253-62.
29. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition. Gastric Cancer 1998;1:10-24.
30. Mor O, Ranzani GN, Ravia Y, et al. DNA amplification in human gastric carcinomas. Cancer Genet Cytogenet 1993;65:111-4.
31. Kozma L, Kiss L Hajdu J, Szentkereszty Z, Szakall S, Ember I. C-myc amplification and cluster analysis in human gastric carcinoma. Anticancer Res 2001;21:707-10.
32. Yokota T, Yoshimoto M, Akiyama F, et al. Frequent multiplication of chromosomal region 8q24.1 associated with aggressive histologic types of breast cancers. Cancer Lett 1999;139:7-13.
33. Fejzo MS, Godfrey T, Chen C, Waldman F, Gray JW. Molecular cytogenetic analysis of consistent abnormalities at 8q12-q22 in breast cancer. Genes Chromosomes Cancer 1998;22:105-13.
34. Colins C, Romments JM, Kowbel D, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 1999;87:5983-7.
35. Rosenberg C, Geelen E, Ijszenga MJ, et al. Spectrum of genetic changes in gastro-esophageal cancer cell lines determined by an integrated molecular cytogenetic approach. Cancer Genet Cytogenet 2002;135:35-41.
36. Mori Y, Matsunaga M, Abe T, et al. Chromosome band 16q24 is frequently deleted in human gastric cancer. Br J Cancer 1999;80:556-62.
37. Nishioka N, Yashiro M, Inoue T, Matsuoka T, Ohira M, Hirakawa K. A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q12.2. Int J Oncol 2001;18:317-22.
38. Huiping C, Kristjansdottir S, Jonasson JG, Magnusson J, Egilsson V, Ingvarsson S. Alteration of E-cadherin and β-catenin in gastric cancer. BMC Cancer 2001;1:16.
39. Murahashi K, Yashiro M, Takenaka C, Matsuoka T, Ohira M, Chung KH. Establishment of a new scirrhous gastric cancer cell line with loss of heterozygosity at E-cadherin locus. Int J Oncol 2001;19:1029-33.
40. Elo JP, Harkonen P, Kyllonen AP, Lukkarinen O, Vihko P. Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behavior of the disease, recurrent growth, poor differentiation of the tumor and poor prognosis for the patient. Br J Cancer 1999;79:156-60.
41. Bandoh K, Nagai H, Matsumoto S, et al. Identification of a 1-Mb common region at 16q24.1-24.2 deleted in hepatocellular carcinoma. Genes Chromosomes Cancer 2000;28:38-44.